Tweet
Arch Virol. 2019 Jun 21. doi: 10.1007/s00705-019-04328-4. [Epub ahead of print]
A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
Nemoto M1, Yamayoshi S2, Bannai H3, Tsujimura K3, Kokado H3, Kawaoka Y2,4, Yamanaka T3.
Author information
Abstract
Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.
PMID: 31227892 DOI: 10.1007/s00705-019-04328-4
A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
Nemoto M1, Yamayoshi S2, Bannai H3, Tsujimura K3, Kokado H3, Kawaoka Y2,4, Yamanaka T3.
Author information
Abstract
Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.
PMID: 31227892 DOI: 10.1007/s00705-019-04328-4